US CDC Advisory Panel Recommends Full Approval of Moderna COVID-19 Vaccine
[Asia Economy New York=Special Correspondent Joselgina] The advisory committee of the U.S. Centers for Disease Control and Prevention (CDC) recommended on the 4th (local time) that the pharmaceutical company Moderna's COVID-19 vaccine be formally approved.
According to CNN, the CDC's Advisory Committee on Immunization Practices (ACIP) held a meeting that day and unanimously voted to recommend that the CDC formally approve Moderna's COVID-19 vaccine for administration to adults aged 18 and over.
Hot Picks Today
"Rather Than Endure a 1.5 Million KRW Stipend, I'd Rather Earn 500 Million in the U.S." Top Talent from SNU and KAIST Are Leaving [Scientists Are Disappearing] ①
- "Not Jealous of Winning the Lottery"... Entire Village Stunned as 200 Million Won Jackpot of Wild Ginseng Cluster Discovered at Jirisan
- "I'll Stop by Starbucks Tomorrow": People Power Chungbuk Committee and Geoje Mayoral Candidate Face Criticism for Alleged 5·18 Demeaning Remarks
- "Chinese AI Models Cannot Defeat U.S. Big Tech"...Goldman Sachs Forecast
- "How Did an Employee Who Loved Samsung End Up Like This?"... Past Video of Samsung Electronics Union Chairman Resurfaces
Earlier, the U.S. Food and Drug Administration (FDA) formally approved Moderna's COVID-19 vaccine on the 31st of last month. The brand name of Moderna's COVID-19 vaccine is 'Spikevax.'
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.